all report title image

ANTIMICROBIAL THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Antimicrobial Therapeutics Market, By Drug Class (Antibacterials, Antivirals, Antifungals, Antiparasitics), By Route of Administration (Oral, Topical, Injectable, Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections (UTIs), Skin and Soft Tissue infections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections and others, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)

  • Published In: 29 Apr, 2026
  • Code: CMI5845
  • Page number: 165
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Antimicrobial Therapeutics, By Drug Class
      • Market Antimicrobial Therapeutics, By Route of Administration
      • Market Antimicrobial Therapeutics, By Disease Indication
      • Market Antimicrobial Therapeutics, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Antimicrobial Therapeutics Market , By Drug Class, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Antibacterials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Antivirals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Antifungals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Antiparasitics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  5. Antimicrobial Therapeutics Market , By Route of Administration, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  6. Antimicrobial Therapeutics Market , By Disease Indication, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Respiratory Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Urinary Tract Infections (UTIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Skin and Soft Tissue Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Sexually Transmitted Infections (STIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Gastrointestinal Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Central Nervous System Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  7. Antimicrobial Therapeutics Market , By Distribution Channel, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  8. Antimicrobial Therapeutics Market , By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Country, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country 2022–2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn )
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn )
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn )
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,2021 - 2033, (US$ Bn )
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn )
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2021 - 2033, (US$ Bn )
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Gilead Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Allergan plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Alembic Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section

    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on “Global Antimicrobial Therapeutics Market” - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.